Sequencing-Based Tropism Testing for HIV May Be Feasible, if Not Yet Commercially Viable

Testing the ability of Roche's 454 GS FLX to detect viral tropism, researchers sequenced the viruses of 14 HIV patients, selecting specifically for the V3 loop of the virus, the region that allows it to infect human immune cells.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.